A detailed history of Financial Management Professionals, Inc. transactions in Exelixis, Inc. stock. As of the latest transaction made, Financial Management Professionals, Inc. holds 16 shares of EXEL stock, worth $574. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16
Holding current value
$574
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$21.96 - $27.6 $351 - $441
16 New
16 $0
Q1 2023

Apr 13, 2023

BUY
$16.3 - $19.41 $391 - $465
24 New
24 $0
Q2 2022

Jul 12, 2022

SELL
$17.44 - $23.16 $802 - $1,065
-46 Closed
0 $0
Q1 2022

Apr 27, 2022

BUY
$17.03 - $22.67 $783 - $1,042
46 New
46 $1,000

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.6B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Financial Management Professionals, Inc. Portfolio

Follow Financial Management Professionals, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Management Professionals, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Management Professionals, Inc. with notifications on news.